ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, featuring promising advancements throughout many clinical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, additional dependable alternative for therapeutic